CYP24A1 and breast carcinoma: The subgroup analysis showed that low CYP24A1 expression indicated a poor overall survival of patients with basal (P = 0.0049), HER2 (P = 0.044), Lum A (P = 0.11) and Lum B (P = 0.013) breast cancer.